These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11686002)

  • 21. Effects of oxidized low-density lipoprotein on vascular contraction and relaxation: clinical and pharmacological implications in atherosclerosis.
    Cox DA; Cohen ML
    Pharmacol Rev; 1996 Mar; 48(1):3-19. PubMed ID: 8685247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oxysterols from oxidized LDL are cytotoxic but fail to induce hsp70 expression in endothelial cells.
    Pirillo A; Zhu W; Roma P; Galli G; Caruso D; Pellegatta F; Catapano AL
    FEBS Lett; 1999 Nov; 462(1-2):113-6. PubMed ID: 10580102
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oxidized low-density lipoprotein and atherosclerosis.
    Devaraj S; Jialal I
    Int J Clin Lab Res; 1996; 26(3):178-84. PubMed ID: 8905449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beyond oxidized LDL: the initiation and progression of atherosclerosis.
    Hirose N; Arai Y; Kawamura M; Shigematu H
    Keio J Med; 1996 Jun; 45(2):90-4. PubMed ID: 8683904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals.
    Takahashi K; Takeya M; Sakashita N
    Med Electron Microsc; 2002 Dec; 35(4):179-203. PubMed ID: 12658354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of oxysterol-induced apoptosis.
    Panini SR; Sinensky MS
    Curr Opin Lipidol; 2001 Oct; 12(5):529-33. PubMed ID: 11561172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antioxidants, lipoprotein oxidation, and arterial function.
    Bruckdorfer KR
    Lipids; 1996 Mar; 31 Suppl():S83-5. PubMed ID: 8729099
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of oxidized low density lipoprotein in atherogenesis.
    Witztum JL; Steinberg D
    J Clin Invest; 1991 Dec; 88(6):1785-92. PubMed ID: 1752940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Relationship between oxysterols and atherosclerosis].
    Feng ZH; Cheng S
    Sheng Li Ke Xue Jin Zhan; 1999 Jan; 30(1):23-8. PubMed ID: 12532844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxidation-dependent effects of oxidized LDL: proliferation or cell death.
    Han CY; Pak YK
    Exp Mol Med; 1999 Dec; 31(4):165-73. PubMed ID: 10630369
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antioxidants and atherosclerosis: a current assessment.
    Chisolm GM
    Clin Cardiol; 1991 Feb; 14(2 Suppl 1):I25-30. PubMed ID: 2044256
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The oxidative modification hypothesis of atherogenesis: an overview.
    Chisolm GM; Steinberg D
    Free Radic Biol Med; 2000 Jun; 28(12):1815-26. PubMed ID: 10946223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antioxidant properties of macrophages toward low-density lipoprotein.
    Baoutina A; Dean RT; Jessup W
    Trends Cardiovasc Med; 2001 Jan; 11(1):1-7. PubMed ID: 11413045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxidized low density lipoproteins alter macrophage lipid uptake, apoptosis, viability and nitric oxide synthesis.
    Yang X; Galeano NF; Szabolcs M; Sciacca RR; Cannon PJ
    J Nutr; 1996 Apr; 126(4 Suppl):1072S-5S. PubMed ID: 8642435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro cell injury by oxidized low density lipoprotein involves lipid hydroperoxide-induced formation of alkoxyl, lipid, and peroxyl radicals.
    Coffey MD; Cole RA; Colles SM; Chisolm GM
    J Clin Invest; 1995 Oct; 96(4):1866-73. PubMed ID: 7560078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular action of vitamin E in lipoprotein oxidation: implications for atherosclerosis.
    Thomas SR; Stocker R
    Free Radic Biol Med; 2000 Jun; 28(12):1795-805. PubMed ID: 10946221
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxidized low density lipoprotein: atherogenic and proinflammatory characteristics during macrophage foam cell formation. An inhibitory role for nutritional antioxidants and serum paraoxonase.
    Kaplan M; Aviram M
    Clin Chem Lab Med; 1999 Aug; 37(8):777-87. PubMed ID: 10536926
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual role of oxidized LDL on the NF-kappaB signaling pathway.
    Robbesyn F; Salvayre R; Negre-Salvayre A
    Free Radic Res; 2004 Jun; 38(6):541-51. PubMed ID: 15346645
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of biologically modified low-density lipoprotein in atherosclerosis.
    Carew TE
    Am J Cardiol; 1989 Oct; 64(13):18G-22G. PubMed ID: 2679026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low density lipoprotein oxidation and atherogenesis: from experimental models to clinical studies.
    Napoli C
    G Ital Cardiol; 1997 Dec; 27(12):1302-14. PubMed ID: 9470066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.